Xintela AB Valuation
| XINT Stock | SEK 0.32 0.01 3.23% |
Xintela AB seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of Xintela AB from examining the company fundamentals such as Shares Owned By Insiders of 58.76 %, current valuation of 122.93 M, and Return On Asset of -1.14 as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Xintela AB's price fluctuation is out of control at this time. Calculation of the real value of Xintela AB is based on 3 months time horizon. Increasing Xintela AB's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Xintela AB's intrinsic value may or may not be the same as its current market price of 0.32, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.32 | Real 0.3 | Hype 0.31 |
The intrinsic value of Xintela AB's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Xintela AB's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Xintela AB helps investors to forecast how Xintela stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Xintela AB more accurately as focusing exclusively on Xintela AB's fundamentals will not take into account other important factors: Xintela AB Total Value Analysis
Xintela AB is at this time anticipated to have takeover price of 122.93 M with market capitalization of 143.79 M, debt of 0, and cash on hands of 11.14 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Xintela AB fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
122.93 M | 143.79 M | 0 | 11.14 M |
Xintela AB Asset Utilization
One of the ways to look at asset utilization of Xintela is to check how much profit was generated for every dollar of assets it reports. Xintela AB maintains a negative usage of resources of -1.14 (%), losing kr0.0114 for each kronor of resources held by the company. Inadequate asset utilization attests that the company is being less effective with each kronor of resources it maintains. Specifically, asset utilization of Xintela AB shows how discouraging it operates for each kronor spent on its resources.Xintela AB Ownership Allocation
Xintela AB retains a total of 307.57 Million outstanding shares. Xintela AB owns significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.Xintela AB Profitability Analysis
Net Loss for the year was (58.39 M) with profit before overhead, payroll, taxes, and interest of 2.08 M.About Xintela AB Valuation
The stock valuation mechanism determines Xintela AB's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Xintela AB based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Xintela AB. We calculate exposure to Xintela AB's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Xintela AB's related companies.Xintela AB , a biomedical company, operates in the fields of regenerative medicine and cancer, focusing on cartilage damage and brain tumors. The company was founded in 2009 and is based in Lund, Sweden. Xintela AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 13 people.
8 Steps to conduct Xintela AB's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Xintela AB's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Xintela AB's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Xintela AB's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Xintela AB's revenue streams: Identify Xintela AB's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Xintela AB's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Xintela AB's growth potential: Evaluate Xintela AB's management, business model, and growth potential.
- Determine Xintela AB's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Xintela AB's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Xintela Stock Analysis
When running Xintela AB's price analysis, check to measure Xintela AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xintela AB is operating at the current time. Most of Xintela AB's value examination focuses on studying past and present price action to predict the probability of Xintela AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xintela AB's price. Additionally, you may evaluate how the addition of Xintela AB to your portfolios can decrease your overall portfolio volatility.